SRSF5 and cancer: As expected, a low expression of SRSF5 was associated with TAM resistance (Figure 5C), local cancer recurrence (Figure 5D) and metastasis (Figure 5E) since ineffective TAM treatment can result in cancer recurrence and metastasis [59].